P. Monini

P. Monini, B. Ensoli, G. Alessandri, 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8

R. Gavioli, P. Monini, M. Andreoni, 2002, Immunology.

Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients.

P. Monini, P. Pezzotti, M. Andreoni, 2001, The Journal of infection.

Transcription Pattern of Human Herpesvirus 8 Open Reading Frame K3 in Primary Effusion Lymphoma and Kaposi's Sarcoma

M. Falchi, P. Monini, A. Caputo, 2001, Journal of Virology.

Human herpesvirus-8 and Kaposi's sarcoma: relationship with the multistep concept of tumorigenesis.

P. Monini, B. Ensoli, M. Stürzl, 2001, Advances in cancer research.

Prevalence and Risk Factors for Human Herpesvirus 8 Infection in Northern Cameroon

P. Monini, P. Pezzotti, M. Andreoni, 2000, Sexually transmitted diseases.

Lytic Growth of Human Herpesvirus 8: Morphological Aspects

P. Monini, B. Ensoli, M. Ammendolia, 2000, Ultrastructural pathology.

Does HHV-8 have a protective role on the development of HIV encephalopathy? Italian HIV-Seroconversion Study.

E. Nicastri, P. Monini, P. Pezzotti, 1999 .

Does HHV-8 have a protective role on the development of HIV encephalopathy?

E. Nicastri, A. De Luca, P. Monini, 1999, Neurology.

Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells.

P. Monini, P. Browning, E. Castaños-Vélez, 1999, Journal of the National Cancer Institute.

Molecular Characterization of HIV-1 Subtype C gp-120 Regions Potentially Involved in Virus Adaptive Mechanisms

M. Grigioni, G. D'Avenio, L. Tavoschi, 2014, PloS one.

Characterization of variable regions of the Gp120 protein from HIV-1 subtype C virus variants obtained from individuals at different disease stages in Sub-Saharan Africa

G. D'Avenio, L. Tavoschi, M. Ciccozzi, 2012 .

Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.

G. Gaidano, A. Carbone, A. Gloghini, 2000 .

Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis

G. Gaidano, A. Carbone, A. Gloghini, 2000, British journal of haematology.

Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals

P. Mirandola, P. Monini, R. Dolcetti, 1995, Journal of medical virology.

The helical domain of GBP‐1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines

E. Kremmer, E. Tschachler, P. Monini, 2001, The EMBO journal.

CHAPTER 31 – The fibroblast growth factors

P. Monini, G. Barillari, B. Ensoli, 2003 .

Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease

O. Picconi, S. Moretti, P. Monini, 2019, Vaccines.

Acquired Immunodeficiency Syndrome-Associated Vasculopathy Vascular Endothelial Cell Growth Factor in T Cells: Implications for Infection With Human Immunodeficiency Virus-1 Increases Expression of

L. Eckhart, E. Tschachler, E. Shumay, 2013 .

“cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies”

O. Picconi, S. Moretti, P. Monini, 2017, Expert review of vaccines.

Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine

O. Picconi, P. Monini, S. Bellino, 2015, Expert opinion on biological therapy.

Candidate HIV-1 Tat vaccine development: from basic science to clinical trials.

M. Magnani, P. Monini, A. Caputo, 2006, AIDS.

Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study

O. Picconi, M. Magnani, M. Meschiari, 2019, Front. Immunol..

Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity

P. Monini, S. Bellino, G. Barillari, 2012, AIDS.

HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial

A. Lazzarin, O. Picconi, M. Magnani, 2015, Retrovirology.

Challenges in HIV Vaccine Research for Treatment and Prevention

P. Monini, B. Ensoli, F. Ensoli, 2014, Front. Immunol..

Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART.

O. Picconi, C. Mussini, S. Moretti, 2021, EBioMedicine.

HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial

L. Tavoschi, O. Picconi, M. Magnani, 2016, Retrovirology.

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study

A. Lazzarin, O. Picconi, C. Mussini, 2014, Retrovirology.

HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies

R. Rappuoli, K. Montin, F. Dallocchio, 2012, PloS one.

The therapeutic phase I trial of the recombinant native HIV-1 Tat protein

P. Narciso, A. Lazzarin, M. Magnani, 2008, AIDS.

The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study

A. Lazzarin, O. Picconi, C. Mussini, 2014, Retrovirology.

Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor.

M Stürzl, A. Cereseto, P. Monini, 2001, Molecular biology of the cell.

Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking

G. Damonte, L. Banci, M. Magnani, 2010, Molecular and Cellular Biochemistry.

Human herpesvirus-8 and other viral infections, Papua New Guinea.

P. Monini, M. Andreoni, B. Ensoli, 2001, Emerging infectious diseases.

HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction

A. Sapino, A. Pisacane, O. Picconi, 2020, Molecular Cancer Therapeutics.

HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity.

P. Monini, G. Barillari, B. Ensoli, 2003, The Journal of antimicrobial chemotherapy.

Follow-up Study of Patients With Cervical Intraepithelial Neoplasia Grade 1 Overexpressing p 16 Ink 4 a

P. Monini, S. Costa, G. Barillari, 2013 .

HIV-1 Tat Addresses Dendritic Cells to Induce a Predominant Th1-Type Adaptive Immune Response That Appears Prevalent in the Asymptomatic Stage of Infection1

M. Magnani, A. Scoglio, S. Moretti, 2009, The Journal of Immunology.

the Asymptomatic Stage of Infection Immune Response That Appears Prevalent in Induce a Predominant Th1-Type Adaptive HIV-1 Tat Addresses Dendritic Cells to

M. Magnani, A. Scoglio, S. Moretti, 2009 .

ATL

P. Monini, S. Costa, G. Barillari, 2013, International Journal of Gynecologic Cancer.

Episomal HPV 16 DNA isolated from a cervical carcinoma presents a partial duplication of the early region.

P. Monini, A. Rotola, D. Di Luca, 1989, Virus research.

Downregulation of the major histocompatibility complex class I molecules by human herpesvirus type 8 and impaired natural killer cell activity in primary effusion lymphoma development

D. Rossi, G. Gaidano, A. Carbone, 2005, British journal of haematology.

Erratum: Downregulation of the major histocompatibility complex class I molecules by human herpesvirus type 8 and impaired natural killer cell activity in primary effusion lymphoma development (British Journal of Haematology (2005) 130, (92-95))

D. Rossi, G. Gaidano, A. Carbone, 2005 .

Treatment update for AIDS-related Kaposi's sarcoma.

P. Monini, B. Ensoli, P. Gill, 1999, AIDS (London).

DETECTION OF INCREASED VEGF SERUM CONCENTRATIONS IN HIV-1-INFECTED PATIENTS: IMPLICATIONS FOR AIDS-ASSOCIATED VASCULOPATHY

E. Tschachler, P. Monini, B. Ensoli, 1999 .

Primary Effusion Lymphoma Cells Undergoing Human Herpesvirus Type 8 Productive Infection Produce C-Type Retroviral Particles

P. Monini, F. Nappi, C. Chiozzini, 2008, International journal of immunopathology and pharmacology.

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Infection With Human Immunodeficiency Virus-1 Increases Expression of Vascular Endothelial Cell Growth Factor in T Cells: Implications for Acquired Immunodeficiency Syndrome-Associated Vasculopathy

L. Eckhart, E. Tschachler, E. Shumay, 2016 .

HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial

L. Tavoschi, O. Picconi, M. Magnani, 2016, Retrovirology.

The use of HAART for biological tumour therapy.

P. Monini, G. Barillari, B. Ensoli, 2006, Journal of HIV therapy.

The therapeutic phase I trial of the recombinant native HIV-1 Tat protein

P. Narciso, A. Lazzarin, M. Magnani, 2008, AIDS.

Human herpesvirus DNA in prostate and semen from HIV-negative individuals in Italy.

T. Schulz, P. Monini, P. Rimessi, 1997, AIDS.

Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis

P. Monini, A. Borsetti, A. Cafaro, 2024, International journal of molecular sciences.